Trade Reviews
Trade Review: IOVA
Iovance Biotherapeutics, Inc. (IOVA) was identified using our custom Catalyst Breakout screener. We entered and closed the position on September 29, 2026 for a +5.36% gain. Setup The thesis required a catalyst to push IOVA through resistance and keep buyers in control after the breakout. Entry We entered IOVA